-
EP1576010
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1576010
| EP1576010 - COMPOSITIONS AND METHODS OF THERAPY FOR CANCERS CHARACTERIZED BY EXPRESSION OF THE TUMOR-ASSOCIATED ANTIGEN MN/CA IX [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 27.11.2009 Database last updated on 19.07.2024 | Most recent event Tooltip | 27.11.2009 | Withdrawal of application | published on 30.12.2009 [2009/53] | Applicant(s) | For all designated states Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street Emeryville, CA 94608 / US | [2007/04] |
| Former [2005/38] | For all designated states CHIRON CORPORATION 4560 Horton Street Emeryville California 94608-2916 / US | Inventor(s) | 01 /
WONG, Justin 389 Somerset Road 3 Oakland, CA 94611 / US | 02 /
WINTER, Jill 435 Mount Street Richmond, CA 94805 / US | 03 /
LALEHZADEH, Guita 669 Hillsborough 23 Oakland, CA 94606 / US | 04 /
WARNE, Robert 305 Melvin Court San Leandro, CA 94577 / US | [2005/38] | Representative(s) | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstrasse 4 22607 Hamburg / DE | [N/P] |
| Former [2005/38] | UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE | Application number, filing date | 03749129.7 | 25.08.2003 | [2005/38] | WO2003US26612 | Priority number, date | US20020405577P | 23.08.2002 Original published format: US 405577 P | US20030646934 | 22.08.2003 Original published format: US 646934 | [2005/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004017923 | Date: | 04.03.2004 | Language: | EN | [2004/10] | Type: | A2 Application without search report | No.: | EP1576010 | Date: | 21.09.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.03.2004 takes the place of the publication of the European patent application. | [2005/38] | Search report(s) | International search report - published on: | US | 14.07.2005 | (Supplementary) European search report - dispatched on: | EP | 28.11.2006 | Classification | IPC: | C07K16/00 | [2005/38] | CPC: |
C07K16/30 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C07K16/40 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/38] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON KREBS, CHARAKTERISIERT DURCH EXPRESSION DES TUMORASSOZIIERTEN ANTIGENS MN/CA IX | [2005/38] | English: | COMPOSITIONS AND METHODS OF THERAPY FOR CANCERS CHARACTERIZED BY EXPRESSION OF THE TUMOR-ASSOCIATED ANTIGEN MN/CA IX | [2005/38] | French: | COMPOSITIONS ET PROCEDES THERAPEUTIQUES CONTRE LES CANCERS CARACTERISES PAR L'EXPRESSION DE L'ANTIGENE MN/CA IX ASSOCIE AUX TUMEURS | [2005/38] | Entry into regional phase | 15.03.2005 | National basic fee paid | 15.03.2005 | Search fee paid | 15.03.2005 | Designation fee(s) paid | 15.03.2005 | Examination fee paid | Examination procedure | 23.03.2004 | Request for preliminary examination filed International Preliminary Examining Authority: US | 15.03.2005 | Examination requested [2005/38] | 19.09.2005 | Amendment by applicant (claims and/or description) | 02.06.2009 | Despatch of a communication from the examining division (Time limit: M06) | 23.11.2009 | Application withdrawn by applicant [2009/53] | Fees paid | Renewal fee | 15.03.2005 | Renewal fee patent year 03 | 07.08.2006 | Renewal fee patent year 04 | 03.08.2007 | Renewal fee patent year 05 | 31.03.2008 | Renewal fee patent year 06 | 12.08.2009 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0024913 (BAYER AG [US], et al) [X] 1-40* the whole document * | International search | [X]US5955075 | Examination | - J. SAARNIO ET EL., "Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.", AMERICAN JOURNAL OF PATHOLOGY, (1998), vol. 153, no. 1, pages 279 - 285 |